论文部分内容阅读
截至1991年7月,世界肺移植已超过800例,其中500例以上为单肺移植,双肺移植(连续移植左右单侧肺)已超过150例。对象除肺纤维症、肺气肿外,欧美除α_1抗胰蛋白酶缺乏症、纤维性囊胞症外还包括肺动脉高压症、淋巴管平滑肌肉瘤,此外还有再次移植的病例。1年生存率为65%,目前还可能有所提高。一、肺移植的对象肺移植应以预测18个月内死亡的低肺功能病例为对象,单肺移植以限制性肺功能障碍严重的特发性纤维症居多。此外,还有肺气肿、肺动脉高压症、淋巴管平滑肌肉瘤、类肉瘤病、嗜酸细胞肉芽肿、职业性
As of July 1991, the world has more than 800 lung transplants, of which more than 500 are single lung transplants and more than 150 have double lung transplants (with continuous transplants of left and right unilateral lungs). In addition to pulmonary fibrosis, emphysema, in addition to Europe and the United States in addition to α_1 antitrypsin deficiency, fibrocysticcytosis in addition to pulmonary hypertension, lymphatic leiomyosarcoma, in addition to another case of transplanted. One-year survival rate of 65%, is also likely to increase. First, the target of lung transplantation Lung transplantation should be expected to die within 18 months of low lung function as the object, a single lung transplantation to limit pulmonary dysfunction severe idiopathic fibrosis mostly. In addition, there emphysema, pulmonary hypertension, lymphatic leiomyosarcoma, sarcoidosis, eosinophilic granuloma, occupational